Organization | National University of Ireland

National University of Ireland Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4

Founded: Cork Ireland (1908)

Organization Overview

First Clinical Trial

2002

NCT00510978

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2023

Timeline

NOW

Now

Alternative names

Cork University | Cork University Hospital | Cork University Hospital, Cork, Ireland | Cork University Hospital, Cork, Ireland. | Cork University Hospital & University College Cork | Cork University Maternity Hospital | Cork Universtiy Hospital | Department of Emergency Medicine, Cork University Hopsital, Cork | Dr. Brian Hallahan | Heart Failure Unit, St Vincent's University Hospital | HRB Clinical Research Facility Galway, Ireland | National University Ireland | National University Ireland - Galway | National University of Ireland Galway | National University of Ireland, Galway | National University Of Ireland Galway | National University of Ireland, Galway, Ireland | NATIONAL UNIVERSITY OF IRELAND, GALWAY (NUIG) | National University of ireland - Galway University Hospital -Regenerative Medicine Institute | Professor of Anaesthesia and Intensive Care Medicine, National University of Ireland, Galway, Ireland | School of Food & Nutritional Sciences, University College Cork. | School of Public Health, Physiotherapy and Population Sciences. University College Dublin | Shannon Hernon | Sport Physiologist University College Cork | St Vincent's University | St Vincent's University Hospital | St Vincents University Hospital | St Vincent's University Hospital / AMNCH | St Vincents University Hospital, Elm Park Dublin 4 Ireland | St Vincent's University Hospital, Ireland | St Vincent's University Hospital, University College Dublin | Temple Street Children's University Hospital Dublin and University College | UCC | UCD Clinical Research Centre, St Vincent's University Hospital | UCD School of Medicine and Medical Sciences | University College Cork | University College Cork, Ireland | University College Dublin | University College Dublin, St Vincent's University Hospital | University College Hospital Galway | University College of Dublin, Ireland

Active Ingredients

Drugs in Phase 4 Trials (30)

abacavir (ziagen) (1 trial)

acetylsalicylic acid (aspirin) (3 trials)

albumin (Human) (Plasbumin) (1 trial)

alendronic acid (fosamax) (1 trial)

atorvastatin (lipitor) (2 trials)

calcium carbonate (1 trial)

dalfampridine (ampyra) (1 trial)

dexamethasone (1 trial)

dolutegravir (tivicay) (1 trial)

elexacaftor (Trifakta) (1 trial)

epinephrine (levophed) (1 trial)

fentanyl (Innovar) (1 trial)

flucloxacillin (1 trial)

golimumab (simponi) (1 trial)

ivacaftor (Kalydeco) (1 trial)

lamivudine (epivir) (1 trial)

levobupivacaine (chirocaine) (7 trials)

levothyroxine (Synthroid) (2 trials)

lidocaine (xylocaine) (3 trials)

maraviroc (selzentry) (1 trial)

morphine (5 trials)

naloxone (narcan) (1 trial)

phenoxymethylpenicillin (1 trial)

phytonadione (konakion) (1 trial)

prednisolone (hydeltra) (1 trial)

tenofovir (viread) (1 trial)

tezacaftor (Trifakta) (1 trial)

thiamine (1 trial)

urea (3 trials)

vitamin d3 (14 trials)

Drugs in Phase 3 Trials (14)

allogeneic blood cells (1 trial)

bifidobacterium infantis (1 trial)

bone marrow derived mesenchymal stem cells (1 trial)

colchicine (colbenemid) (2 trials)

cow milk (1 trial)

dopamine (intropin) (1 trial)

epoetin (Epogen) (1 trial)

glucose monohydrate (1 trial)

lactobacillus salivarius (1 trial)

lepicol (1 trial)

liraglutide (victoza) (2 trials)

nivaldipine (1 trial)

sitagliptin (januvia) (3 trials)

sodium chloride (3 trials)

Drugs in Phase 2 Trials (22)

allogeneic adipose derived mesenchymal stem cell (1 trial)

aquamin (2 trials)

autologous mesenchymal stem cells (1 trial)

bumetanide (bumex) (1 trial)

calcium (3 trials)

citalopram (celexa) (1 trial)

docosahexaenoic acid (1 trial)

eicosapentanoic acid (1 trial)

enzalutamide (xtandi) (1 trial)

fish oil (Omegavan) (4 trials)

gabapentin (neurontin) (1 trial)

gliclazide (1 trial)

human fecal microbiota (Reybota) (1 trial)

icosapent ethyl (vascepa) (1 trial)

ivabradine (corlanor) (1 trial)

magnesium oxide (2 trials)

mecasermin (Increlex) (1 trial)

radium-223 (xofigo) (1 trial)

sacubitril (Entresto) (2 trials)

scopolamine (transderm scop) (1 trial)

unfractionated heparin (1 trial)

valsartan (diovan) (2 trials)

Drugs in Phase 1 Trials (8)

autologous bone marrow derived mesenchymal cells (1 trial)

bortezomib (velcade) (1 trial)

capecitabine (xeloda) (1 trial)

cyclophosphamide (cytoxan) (1 trial)

daratumumab (darzalex) (1 trial)

gemcitabine (gemzar) (1 trial)

lithium (lithonate) (1 trial)

uproleselan (1 trial)

Drugs in Other Trials (47)

apple (1 trial)

autologous platelets (1 trial)

bicalutamide (casodex) (1 trial)

bifidobacterium breve (1 trial)

bifidobacterium longum (1 trial)

blackberry juice (1 trial)

b multivitamins (1 trial)

bupivacaine (Exparel) (1 trial)

ceftazidime (fortaz) (1 trial)

cinnamon (1 trial)

clopidogrel (plavix) (1 trial)

coffee (1 trial)

egg albumin-derived peptide (1 trial)

eplerenone (inspra) (1 trial)

ergocalciferol (drisdol) (1 trial)

fiber (1 trial)

Galactose (1 trial)

gfa-918 (1 trial)

lactobacillus reuteri (2 trials)

lactobacillus rhamnosus (1 trial)

l-epigallocatechin (2 trials)

lithothamnion (2 trials)

maltodextrin (1 trial)

mineral rich algae (1 trial)

niacin (1 trial)

nwt-03 (1 trial)

octreotide (sandostatin) (3 trials)

omega-3 fatty acids (Omacor) (1 trial)

prasugrel (effient) (1 trial)

prolycopene (1 trial)

remifentanil (ultiva) (1 trial)

riboflavin (2 trials)

seaweed (3 trials)

semaglutide (Ozempic) (1 trial)

sodium nitrate (4 trials)

soluble fiber (1 trial)

sucrose (1 trial)

ticagrelor (brilinta) (2 trials)

tobramycin (nebcin) (1 trial)

turmeric (1 trial)

vitamin a (1 trial)

vitamin c (3 trials)

vitamin e (2 trials)

whey protein (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Acquired Immunodeficiency Syndrome (Phase 4)

Acute Lung Injury (Phase 2)

Alzheimer Disease (Phase 3)

Anemia, Sickle Cell (Phase 4)

Ankle Fractures (Phase 4)

Asthma (Phase 4)

Atrial Remodeling (Phase 2)

Back Pain (Phase 3)

Bacterial Infections (Phase 4)

Bipolar Disorder (Phase 2)

Bone Demineralization, Pathologic (Phase 4)

Brain Injuries (Phase 3)

Brain Injuries, Traumatic (Phase 3)

Cellulitis (Phase 4)

Cholangitis (Phase 4)

Colitis (Phase 4)

Colitis, Ulcerative (Phase 3)

Colorectal Neoplasms (Phase 1)

Congenital Abnormalities (Phase 2)

Constipation (Phase 3)

Crohn Disease (Phase 4)

Depression (Phase 4)

Depressive Disorder (Phase 4)

Diabetes, Gestational (Phase 3)

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 2 (Phase 2)

Diabetic Nephropathies (Phase 3)

Eclampsia (Phase 4)

Emergencies (Phase 4)

Esophageal Neoplasms (Phase 1)

Fatigue (Phase 4)

Femoral Fractures (Phase 4)

Femoral Neck Fractures (Phase 4)

Fetal Growth Retardation (Phase 4)

Fibrosis (Phase 2)

Fractures, Bone (Phase 4)

Heart Defects, Congenital (Phase 2)

Heart Failure (Phase 4)

Heart Failure, Diastolic (Phase 2)

Hemorrhage (Phase 3)

HIV Infections (Phase 4)

Hypotension (Phase 3)

Hypothyroidism (Phase 4)

Immunologic Deficiency Syndromes (Phase 4)

Infarction (Phase 2)

Infections (Phase 4)

Inflammation (Phase 3)

Intervertebral Disc Degeneration (Phase 3)

Ischemia (Phase 1)

Ischemic Attack, Transient (Phase 3)

Kidney Diseases (Phase 3)

Liver Diseases (Phase 4)

Low Back Pain (Phase 3)

Lung Injury (Phase 2)

Mental Disorders (Phase 2)

Mental Fatigue (Phase 4)

Multiple Myeloma (Phase 1)

Multiple Sclerosis (Phase 4)

Multiple Sclerosis, Chronic Progressive (Phase 4)

Multiple Trauma (Phase 3)

Myocardial Infarction (Phase 2)

Myositis (Phase 2)

Neoplasms (Phase 1)

Neoplasms, Plasma Cell (Phase 1)

Osteoarthritis (Phase 2)

Placenta Diseases (Phase 4)

Pneumonia (Phase 4)

Pre-Eclampsia (Phase 4)

Prostatic Neoplasms (Phase 2)

Psoriasis (Phase 2)

Psychotic Disorders (Phase 2)

Respiratory Distress Syndrome (Phase 2)

Respiratory Insufficiency (Phase 4)

Sclerosis (Phase 4)

Seizures (Phase 2)

Stomach Neoplasms (Phase 1)

Stroke (Phase 3)

Syndrome (Phase 2)

Thyroid Diseases (Phase 4)

Ulcer (Phase 3)

Urinary Tract Infections (Phase 4)

Ventricular Dysfunction, Left (Phase 2)

Ventricular Remodeling (Phase 2)

Vitamin D Deficiency (Phase 2)

Wound Infection (Phase 4)

Wounds and Injuries (Phase 3)

Wounds, Nonpenetrating (Phase 3)

Wounds, Penetrating (Phase 3)

Overview

Highest Phase: Phase 4
# of Trials: 125
# of Trial APIs: 121